FreeCME

Recent Developments in Immuno-oncology: Biomarkers, Pan-tumor Studies, Novel Treatment Combinations, and the Management of Adverse Events

CME: 1.0

April 13, 2020
KEYWORDS Primary Care
/ Print / Reprints /
| Share More
/ Text Size+

Post a comment to this article